Total Payments
$4,759
2024 Payments
$57.32
Companies
47
Transactions
186
Medicare Patients
66,485
Medicare Billing
$4.8M
Payment Breakdown by Category
Food & Beverage$3,146 (66.1%)
Gifts$1,613 (33.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,146 | 185 | 66.1% |
| Gift | $1,613 | 1 | 33.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tosoh Bioscience, Inc. | $1,613 | 1 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $221.78 | 15 | $0 (2024) |
| PFIZER INC. | $211.36 | 15 | $0 (2019) |
| Medtronic USA, Inc. | $196.55 | 7 | $0 (2019) |
| Pernix Therapeutics Holdings, Inc. | $188.08 | 9 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $182.34 | 11 | $0 (2021) |
| Depomed, Inc. | $176.85 | 13 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $162.63 | 10 | $0 (2020) |
| Purdue Pharma L.P. | $153.95 | 12 | $0 (2018) |
| Abbott Laboratories | $142.15 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.32 | 3 | SI-BONE, INC. ($24.87) |
| 2023 | $148.86 | 9 | Collegium Pharmaceutical, Inc. ($71.81) |
| 2022 | $218.43 | 11 | Scilex Pharmaceuticals Inc. ($57.29) |
| 2021 | $553.73 | 34 | Biohaven Pharmaceuticals, Inc. ($70.51) |
| 2020 | $229.80 | 15 | Novartis Pharmaceuticals Corporation ($83.06) |
| 2019 | $270.64 | 13 | ASSERTIO THERAPEUTICS, Inc. ($92.39) |
| 2018 | $616.22 | 35 | AstraZeneca Pharmaceuticals LP ($102.88) |
| 2017 | $2,664 | 66 | Tosoh Bioscience, Inc. ($1,613) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| 04/09/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Opioid Analgesic | ||||||
| 09/18/2023 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Addiction Medicine | ||||||
| 07/20/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Opioid Analgesic | ||||||
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Gastroenterology | ||||||
| 06/20/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Opioid Analgesic | ||||||
| 05/22/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/04/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: Opioid Analgesic | ||||||
| 04/05/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| Category: Opioid Analgesic | ||||||
| 04/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Gastroenterology | ||||||
| 11/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $49.57 | General |
| Category: Drug Infusion Systems | ||||||
| 08/02/2022 | Amneal Pharmaceuticals LLC | LIORESAL (BACLOFEN) (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PRIMARY CARE | ||||||
| 06/16/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $14.49 | General |
| 05/03/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Opioid Analgesic | ||||||
| 03/17/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Pain Management | ||||||
| 01/18/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $21.40 | General |
| 01/18/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Analgesic | ||||||
| 12/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Gastroenterology | ||||||
| 10/25/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 53 | 6,794 | 9,838 | $1.6M | $440,373 |
| 2022 | 57 | 18,778 | 29,806 | $4.2M | $1.3M |
| 2021 | 56 | 22,880 | 39,228 | $5.1M | $1.7M |
| 2020 | 68 | 18,033 | 35,879 | $4.2M | $1.4M |
Total Patients
66,485
Total Services
114,751
Medicare Billing
$4.8M
Procedure Codes
234
All Medicare Procedures & Services
234 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 493 | 799 | $408,289 | $154,502 | 37.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 700 | 1,514 | $302,800 | $91,078 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 607 | 1,231 | $265,896 | $70,791 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 339 | $84,750 | $28,596 | 33.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 50 | 55 | $81,180 | $11,089 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $24,300 | $9,265 | 38.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 47 | 85 | $51,408 | $5,571 | 10.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 51 | 75 | $46,575 | $5,418 | 11.6% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 18 | 20 | $29,000 | $4,020 | 13.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 134 | 137 | $13,974 | $3,974 | 28.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 634 | 1,351 | $13,510 | $3,862 | 28.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 20 | 32 | $24,191 | $3,213 | 13.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 126 | 215 | $10,320 | $2,898 | 28.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 103 | 103 | $9,167 | $2,605 | 28.4% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 16 | 27 | $17,355 | $2,603 | 15.0% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 103 | 103 | $8,961 | $2,571 | 28.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 17 | 34 | $21,888 | $2,454 | 11.2% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 103 | 103 | $7,725 | $2,194 | 28.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 127 | 131 | $7,598 | $2,156 | 28.4% |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | Office | 2023 | 97 | 97 | $7,469 | $2,114 | 28.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 134 | 137 | $7,124 | $2,025 | 28.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 14 | 23 | $14,003 | $1,814 | 13.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 19 | 27 | $13,260 | $1,783 | 13.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 15 | 21 | $13,230 | $1,509 | 11.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 98 | 164 | $8,200 | $1,501 | 18.3% |
About Dr. Frank Hackl, M.D
Dr. Frank Hackl, M.D is a Interventional Pain Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912030404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Hackl, M.D has received a total of $4,759 in payments from pharmaceutical and medical device companies, with $57.32 received in 2024. These payments were reported across 186 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($3,146).
As a Medicare-enrolled provider, Hackl has provided services to 66,485 Medicare beneficiaries, totaling 114,751 services with total Medicare billing of $4.8M. Data is available for 4 years (2020–2023), covering 234 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Tulsa, OK
- Active Since 03/13/2007
- Last Updated 04/28/2016
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1912030404
Products in Payments
- AIA-PACK FOLATE KIT (Medical Supply) $1,613
- ZOHYDRO ER (Drug) $188.08
- Nucynta (Drug) $176.85
- LYRICA (Drug) $167.97
- MOVANTIK (Drug) $162.63
- XTAMPZA (Drug) $150.48
- ADAPTIVESTIM (Device) $148.51
- AIMOVIG (Biological) $116.72
- Gralise (Drug) $92.39
- NURTEC ODT (Drug) $88.84
- Movantik (Drug) $87.84
- ZTLido (Drug) $84.85
- RELISTOR (Drug) $79.46
- Octrode SCS Leads (Device) $78.81
- SYMPROIC (Drug) $70.58
- BELBUCA (Drug) $67.27
- Horizant (Drug) $55.71
- Amitiza (Drug) $54.03
- Proclaim IPG (Device) $50.11
- SYNCHROMEDII (Device) $49.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Pain Medicine Doctors in Tulsa
Bhadresh Bhakta, Md, MD
Interventional Pain Medicine — Payments: $11,504
Interventional Pain Medicine $11,504
Dr. Samuel Korbe, M.d, M.D
Interventional Pain Medicine — Payments: $8,610
Interventional Pain Medicine $8,610
Dr. Gerald Hale, D.o, D.O
Interventional Pain Medicine — Payments: $2,653
Interventional Pain Medicine $2,653
Stephen Lester, Md, MD
Interventional Pain Medicine
Interventional Pain Medicine